FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Right Issue Status: Closed [18th Apr 2022 to 27th Apr 2022]
Makers Laboratories' right issue of 14.75 Cr opens for subscription from 18 April to 27 April 2022. The company issues 1 right equity shares for every 5 fully paid-up equity shares held on the record date, 1 April 2022. The face value of a share is Rs. 10 per share and the right issue price is fixed at Rs. 150 per share. Stay updated with us to know more about the Makers Laboratories Rights Issue including issue size, right issue entitlement, terms of payment, and more.
The right issue aims to raise funds for the below objectives;
Makers Laboratories Issue Details | Values |
---|---|
Category | RightIssue |
Right Issue Issue Size (Shares) | 9.83 Lakhs |
Right Issue Issue Size (Amount) | ₹14.75 Cr |
Face Value | ₹10 Per Equity Share |
Right Issue - Issue Price | ₹150 per share |
Right Issue Record Date | 1st Apr 2022 |
Right Issue Entitlement | 1 right equity shares for every 5 fully paid-up equity shares held on the Record date |
Right Issue Terms of payment | The full amount of Rs. 150/share is payable on the application. |
Listing At | BSE |
BSE Code | 506919 |
NSE Code |
In this section we have covered all important dates related to Makers Laboratories Right Issue. Dates are updated as they are announced. The most noted dates are Right Issue start date and Right Issue end date, which one should use to participate in Right Issue.
Right Issue Activity | Date |
---|---|
Right Issue Issue Open Date | 18th Apr 2022 |
Right Issue Issue Close Date | 27th Apr 2022 |
Basis of Allotment Finalisation Date* | 5th May 2022 |
Refunds Initiation* | 6th May 2022 |
Credit of Shares to Demat Account* | 9th May 2022 |
Right Issue Listing Date* | 11th May 2022 |
* - Tentative Dates
Zerodha Trade@20
Makers Laboratories Limited is an Indian pharmaceutical company with a key focus on branded generics. It is primarily engaged in the marketing of Branded Generic Pharmaceutical Formulations that are used by the dispensing doctors, nursing homes, and hospitals. Its product portfolio includes a range of General Health Therapeutic segments and Duramol (Paracetamol), Artemak-AB, Loroquin, Nimuwin, Coffwin, and Exylin are its top products.
It has 2 manufacturing facilities located in the GIDC Industrial State, Naroda, Ahmedabad and also has warehouses in Ahmedabad, Ambala, and Mumbai. Our Company has a product range of around 170 products in therapy segments such as Anti Malarials, Analgesics, Anti Pyretics, Anti-Allergy, Nutritional Supplements, Dermatology, Ophthalmic, Anti Diabetic, Anti-Hypertensives etc. Arofen Plus Gel, Corima, Winlyte, Nimuwin Plus, and Artemak are its top popular brands.
Past performance and financial results of Makers Laboratories.
Makers Laboratories Financials (₹ in Lacs) | 31-Mar-2021 | 31-Mar-2020 |
---|---|---|
Total Assets | ₹7,911.59 | ₹7,387.49 |
Total Income | ₹4,482.54 | ₹5,162.21 |
Net Profit/Loss | ₹(161.66) | ₹(12.38) |
The table below is live update of Right Issue bidding details from NSE and BSE.
Makers Laboratories Right Issue Offer Document (Letter of Offer) >>Document
Makers Laboratories Right Issue Offer Document (Letter of Offer) >>Makers Laboratories Right Issue Red Herring Prospectus is not yet available.
Makers Laboratories Right Issue Online Application (Registrar & Transfer Agent) >>Online Application
Makers Laboratories Right Issue Online Application (Registrar & Transfer Agent) >>Makers Laboratories Right Issue RTA information is not yet available.
Last Updated on 2022-04-19T16:55:25+00:00